TokenPost topic

Summit Therapeutics

1 TokenPost story is tagged Summit Therapeutics. The newest appear first.

Latest Summit Therapeutics stories

• Summit Reports 25% Lower Death Risk in Biliary Tract Cancer Trial

  Median overall survival was 14.9 months with ivonescimab and chemotherapy, versus 12.1 months with durvalumab and chemotherapy in the late-stage trial conducted in China.

  Oct 25, 2026, 2:41 PM EDT · Business